Danaher Corporation (DHR) vs Natera, Inc. (NTRA)
- Danaher Corporation DHR 228.97 −1.09%
- Natera, Inc. NTRA 391.98 −3.16%
Danaher Corporation and Natera, Inc. are both Diagnostics & Research companies. Danaher Corporation is the larger, with a market value of $162.7B against $58.4B — 2.8× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Danaher Corporation trades at 40.5×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 4.56%. Danaher Corporation has the higher net margin (16.0% vs −7.11%) and the higher return on invested capital (4.37% vs −22.3%). Across the 20 metrics below, Danaher Corporation leads on 14 and Natera, Inc. on 6.
Valuation
Profitability
| Metric | DHR | NTRA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 58.51% | 65.23% | 50.89% |
| Operating margin | 20.42% | (10.70%) | (8.57%) |
| Net margin | 15.95% | (7.11%) | (6.37%) |
| Free cash flow margin | 21.86% | 3.11% | 0.00% |
| Return on equity | 7.63% | (12.54%) | (2.92%) |
| Return on assets | 4.60% | (8.71%) | (6.71%) |
| Return on invested capital | 4.37% | (22.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack